Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin - Wikidata - wikimedia - TriplyDB

Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin

Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin

http://www.wikidata.org/entity/Q36999721

about

An update on pharmacotherapy for the treatment of fibromyalgia.Fixed-site high-frequency transcutaneous electrical nerve stimulation for treatment of chronic low back and lower extremity pain Novel Pharmaceutical Options For Treating Fibromyalgia.Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia.Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.An update on emerging drugs for fibromyalgia treatment.Normalizing fibromyalgia as a chronic illness.Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.Treatment of fibromyalgia.

P2860

Q34477510-4D95166F-78A1-4C9F-AB8A-3FC73C30A90A Q37070451-B3157545-A7EC-4F92-B483-B8D7DD92652C Q38705677-7BFFBFF0-4DFD-4DFE-A54E-69B91061B4AB Q38832018-F465E354-0660-4562-86C9-DCEC9618EA0A Q39178169-AA7CD09A-D68E-4445-99F3-48E08909A8D6 Q46436575-0F5CC73A-7CC5-4EFF-94F2-3FB63CB40807 Q47292988-FDA488CC-A79F-4B06-B013-39B74F954B53 Q47652632-03546D61-0628-4CDE-A969-0C69E48A3F24 Q52681690-6766FE03-698B-44E9-BC6B-61BCC1C6645B Q55036632-CBC197C9-E4C9-435F-9363-A519E1DCE352

P2860

Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin

http://www.wikidata.org/entity/Q36999721

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Milnacipran combined with preg ...... omplete response to pregabalin

@en

type

label

Milnacipran combined with preg ...... omplete response to pregabalin

@en

prefLabel

Milnacipran combined with preg ...... omplete response to pregabalin

@en

P1433

Q36999721-864DBBE7-7B03-450B-A133-6BD77E354314

P1476

Q36999721-D52A47C3-E06C-4F86-AF05-3FFB5CAAAA82

P2093

Q36999721-0C76326D-60D3-43C5-B2B8-FBAD59CC771E

Q36999721-0CA3CB1D-6D5F-45BF-B526-3493C9A489BC

Q36999721-262C22EB-CDF9-48AE-B355-9A4E9F1F638F

Q36999721-53F05DA2-13B8-45F7-8129-CC6DE21FADF2

Q36999721-7C94ED41-CE75-495C-A897-56FFABC9D493

Q36999721-C6E19EDE-99A8-4CF6-A684-86E96EFA3074

P2860

Q36999721-0239A232-F1EF-43AA-9CB7-070D841982EC

Q36999721-138C24B5-B105-43F7-B41C-ACE5D4783D0B

Q36999721-1ADC9D46-A7D5-424A-B207-9D51D6C36C07

Q36999721-26AC80DD-C892-4737-9A01-0D230F502F08

Q36999721-2D6444CC-B40B-46E2-911E-7F443FF5F71A

Q36999721-32BD3588-463E-4591-AAE3-E904838CD363

Q36999721-4D296541-D595-4EAE-B39A-AFFB94E998B6

Q36999721-5AF0983B-CA91-4E9C-BD36-78A87D5CC0BF

Q36999721-62C7B7A8-CD9F-43F3-ADAF-CC53DE1FD92A

Q36999721-634B93E9-26C5-417A-9C12-F8AC4DD43066

P304

Q36999721-E1709021-9483-4C47-9314-F063FCF73F87

P31

Q36999721-F2996B9D-7B2A-4A7A-BBEF-638F62AE59A7

P356

Q36999721-583D39AF-C280-45AA-89FF-D6CF9F14ED66

P433

Q36999721-61698CCD-44EE-4CCE-8AFB-FB865DF9481D

P478

Q36999721-9F7A6F6B-BF7D-49B3-BF25-61CC85675F95

P577

Q36999721-C7FDC4B1-BE05-4B9E-B6F5-11815686C61D

P698

Q36999721-479E3994-0D53-49ED-9D38-B6E3C6FFCFDC

P921

Q36999721-DE3D22B6-2E06-4ACD-A421-84310FDB4022

P932

Q36999721-58487483-6BAD-4F5F-B65B-FC7EC958AA16

P356

1759720X13483894

P1433

Therapeutic advances in musculoskeletal disease

P1476

Milnacipran combined with preg ...... omplete response to pregabalin

@en

P2093

Joel M Trugman

http://www.w3.org/2001/XMLSchema#string

Mildred V Farmer

http://www.w3.org/2001/XMLSchema#string

Philip J Mease

http://www.w3.org/2001/XMLSchema#string

R Michael Gendreau

http://www.w3.org/2001/XMLSchema#string

Robert H Palmer

http://www.w3.org/2001/XMLSchema#string

Yong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

An Inventory for Measuring Depression

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

Clinical manifestations and diagnosis of fibromyalgia.

Addressing and advancing the problem of missing data.

Role and rationale for the use of milnacipran in the management of fibromyalgia

Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study.

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study.

Improving the recognition and diagnosis of fibromyalgia.

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

P304

113-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X13483894

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23858335

http://www.w3.org/2001/XMLSchema#string

P921

P932

3707344

http://www.w3.org/2001/XMLSchema#string